A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7806881 in Healthy Participants
Clinical trial NCT07271693 · RECRUITING
Trial details
- NCT number
- NCT07271693
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-22
- Primary completion
- 2027-03-01
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.